Social adjustment in survivors of pedatric acute lymphoblastic leukemia (ALL) and solid tumours
Summary
Thanks to many advances in treatment, most children diagnosed with pediatric cancer or solid tumours will survive. The treatments needed to cure these conditions, however, can negatively impact survivors' health and psychological well-being. Some survivors of experience social difficulties. Social difficulties are a serious health risk that may be comparable to the health risks associated with drinking and smoking. Yet, we do not understand why these survivors may have social difficulties. We need to understand this in order to find the best way to treat these problems.
We are recruiting survivors of pediatric cancer and survivors of solid tumours to participate and complete tests that will assess aspects of their social function. Their parents, teachers and classroom peers will also complete measures designed to assess the social function of survivors.
The goal of the current study is to identify some of the risk and protective factors that might be contributing to social difficulties in survivors of pediatric cancer or solid tumoursThis will help us learn to better identify which survivors may be at greatest risk of social difficulties and to design better treatments to help these survivors.
Eligibility
Eligible ages: 8 to 17
Accepts healthy participants: Yes
Inclusion criteria:
We are looking for participants who:
1) have a history of acute lymphoblastic leukemia or solid tumours
2) at least 24 months post active treatment
3) are currently 8-17 years of age
4) can fluently speak and read English
5) are a current resident of Alberta
Exclusion criteria:
We will not be able to study participants who:
1) were treated with CRT or Bone Marrow Transplant (BMT)
2) have a history of cancer or tumour relapse
3) have a major genetic or neurodevelopmental disorder (e.g., Down’s syndrome, Autism Spectrum Disorder)
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
For more information or to participate, please email the Care4Kids research lab.
Principal investigator:
Fiona Schulte
Clinical trial:
No
REB-ID:
HREBA.CC-16-0661